Investor Relations
Press Releases
March 6, 2023
Allakos Provides Business Update and Reports Fourth Quarter and Full Year 2022 Financial Results
November 29, 2022
Allakos Announces Publication of AK006 Mechanism of Action Manuscript in Communications Biology
November 10, 2022
Allakos Presents Preclinical Data on AK007, a Siglec-10 Antagonist Antibody, at the Society for Immunotherapy of Cancer’s 37th Annual Meeting